BioSpace News Archive

Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that new data will be presented at the Heart Failure Society of America (HFSA) Virtual Annual Scientific Meeting 2020 taking place online from September 30, 2020 – October 6, 2020. The new data include analyses characterizing real-world patients with heart failure with reduced ejection fraction (HFrEF) representative of patients in GALACTIC-HF ( G lobal A pproach to L o

AbCellera and IGM Biosciences, Inc. (Nasdaq: IGMS), announced today that they have entered into a multi-year, multi-target strategic research collaboration and license agreement to facilitate the discovery and development of novel IgM antibodies. AbCellera will generate panels of antibodies for multiple therapeutic targets identified by IGM using its full-stack, AI-powered antibody discovery technol

The COVID-19 pandemic and recent racial turmoil have brought to the national forefront systemic racial and social inequities that create heath disparities that devastate families and communities of color throughout the U.S.

This year, a flu shot is more important than ever. That’s why California hospitals, physicians and public health officials are joining with a coalition of health care stakeholders, social service organizations and governmental agencies to launch the statewide “FightFluTogether” campaign.

Today, Senator Jack Reed (D-RI) introduced the TRANSPLANT Act (S. 4762), which will provide for the timely reauthorization of the C.W. Bill Young Transplantation Program (Program). The National Marrow Donor Program®(NMDP)/Be The Match® applauds the leadership of Senator Reed and urges Congress to act quickly to reauthorize the Pr

APEIRON Biologics AG today announced that first, encouraging data with its clinical drug candidate APN01 (rhsACE2) to treat severe COVID-19 were published in the peer-reviewed journal The Lancet Respiratory Medicine 1.

Coming Sept. 26, Queen Latifah to host #Act4Impact livestream event, nationally presented by CVS Health, to raise funds for communities hardest hit by COVID-19 [24-September-2020] CHICAGO , Sept. 24, 2020 /PRNewswire/ -- On September 26 , in an effort to defeat COVID-19, Queen Latifah is hosting #Act4Impact, a livestream fundraising event to benefit the American Lu

Prelude Therapeutics Incorporated (Nasdaq: PRLD), a clinical-stage precision oncology company, today announced the pricing of its initial public offering of 8,325,000 shares of its common stock at a public offering price of $19.00 per share

OliX Pharmaceuticals, Inc. (KOSDAQ: 226950), a leading developer of RNAi therapeutics, announced today the submission of an Investigational New Drug (IND) application to the US Food and Drug Administration (FDA) to evaluate the efficacy of OLX10010 as an adjunct therapy to reduce the recurrence of hypertrophic scars after scar revision surgery.

BioDuro, a global life science research and development organization backed by Advent International (“Advent”), and Sundia, a leading contract research and manufacturing organization, today announced that they have partnered to create one of the largest CRDMOs (contract rese